Aura Biosciences, Inc. logo AURA - Aura Biosciences, Inc.

NEXT EARNINGS: Mar 23, 2026 (in 26 days) EPS Est: $-0.43
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $22.75 DETAILS
HIGH: $25.00
LOW: $19.00
MEDIAN: $23.50
CONSENSUS: $22.75
UPSIDE: 300.53%
Market Cap: 360.70M
Volume: 160,588
Avg Volume: 191,213
52 Week Range: 4.345-7.73
Sector: Healthcare
Industry: Biotechnology
Beta: 0.46
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 106
IPO Date: 2021-10-29
EPS (TTM): -1.75
P/E Ratio: -4.70
Revenue (TTM): N/A
Total Assets: 182.50M
Total Debt: 18.77M
Cash & Equiv: 31.69M
Rev Growth (5Y): N/A
EPS Growth (5Y): N/A
FCF Growth (5Y): N/A
ROCE: -57.4%
Debt/Equity: 0.12

Earnings History

Date EPS Actual EPS Est EPS Surprise Rev Actual Rev Est Rev Surprise
2025-11-13 $-0.40 $-0.46 +13.0%
2025-08-13 $-0.47 $-0.49 +4.1%
2025-05-15 $-0.55 $-0.47 -17.0%
2025-03-24 $-0.52 $-0.43 -20.9%
2024-11-12 $-0.42 $-0.44 +4.5%
2024-08-08 $-0.41 $-0.45 +8.9%
2024-05-09 $-0.40 $-0.51 +21.6%
2024-03-27 $-0.50 $-0.39 -28.2% $2.1M

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019
Revenue 0 0 0 0 0 0
Net Income (86.92M) (76.41M) (58.76M) (35.25M) (22.21M) (24.20M)
EPS -1.75 -1.93 -1.96 -1.58 -1.03 -0.01
Total Assets 182.50M 255.07M 223.94M 160.03M 22.10M 37.05M
Total Debt 18.77M 19.56M 20.86M 975,000 15,000 49,000
Cash & Equivalents 31.69M 41.06M 121.58M 149.06M 17.39M 32.47M
Operating Cash Flow (79.81M) (63.85M) (54.60M) (32.41M) (24.32M) (20.67M)
Free Cash Flow (81.06M) (64.56M) (55.70M) (34.53M) (25.09M) (22.89M)
FCF per Share -1.63 -1.63 -1.86 -1.18 -0.86 -0.01
Book Value 151.97M 225.85M 195.58M 152.31M 19.36M 30.76M
Cash & ST Investments 151.09M 226.15M 188.81M 149.06M 17.39M 32.47M
ROC Equity -0.57 -0.34 -0.30 -0.23 -1.15 -0.79